TickerFacts.

Zevra Therapeutics, Inc. (ZVRA): EPS (Diluted)

Annual figures by period end, from SEC filings.

Stock splits: 1-for-16, first reflected in a filing dated 2021-03-12. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

$1.35
Year ended 2025-12-31
2020-12-31: -$3.212021-12-31: -$2.112024-12-31: -$2.282025-12-31: $1.35$1.35
2020-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$1.35n/m2026-03-09, From 2025-01-01
2024-12-31-$2.28n/a2026-03-09, From 2024-01-01
No annual figure between 2021-12-31 and 2024-12-31.
2021-12-31-$2.11n/m2022-03-31, From 2021-01-01
2020-12-31-$3.21n/a2022-03-31, From 2020-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Zevra Therapeutics, Inc. (ZVRA)2025-12-31$1.35n/m
Zymeworks Inc. (ZYME)2025-12-31-$1.08n/m
Gyre Therapeutics, Inc. (GYRE)2025-12-31$0.02-60.0%
Siga Technologies Inc (SIGA)2025-12-31$0.32-61.0%
Xencor Inc (XNCR)2025-12-31-$1.24n/m
Cytokinetics Inc (CYTK)2025-12-31-$6.54n/m
Lifecore Biomedical, Inc. (LFCR)2025-05-25-$1.27n/m
Standard Biotools Inc. (LAB)2025-12-31-$0.20n/m
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31-$1.74n/m

Compare ZVRA, ZYME, GYRE, SIGA side by side · Screen every company in Pharmaceutical Preparations ↗